Trump Administration
Refine Search
Pharmaceutical
A federal judge in Rhode Island has issued a sweeping order preventing the Trump administration from cutting $11 billion in public health grants, a move that preserves critical funding for 23 states and the District of Columbia as legal proceedings continue. 19 May 2025
Pharmaceutical
In a world where western firms increasingly seek to ingratiate themselves with Middle Eastern leaders and investors, a Saudi company has sought to curry favor with US President Donald Trump in an announcement on pharma manufacturing. 15 May 2025
Pharmaceutical
US Department of Health and Human Services (HHS) Secretary Robert F Kennedy Jr (RFK Jr) has spoken in defence of his proposed HHS budget for fiscal year 2026 to the Senate Health, Education, Labor, and Pensions (HELP) Committee. 15 May 2025
Pharmaceutical
US President Donald Trump released an executive order on May 12 calling for a 30-day negotiation period between the Department of Health and Human Services (HHS) and the biopharma industry, with the threat of a rule from the Centers for Medicare and Medicaid Services (CMS) to lower US drug prices if no deal is reached. 14 May 2025
Pharmaceutical
US pharma stocks regained ground Monday after Donald Trump signed an executive order aiming to slash prescription drug prices, a move that initially rattled investors but left many analysts unconvinced about its impact. 13 May 2025
Pharmaceutical
US President Donald Trump sent shivers through the pharmaceutical industry as he vowed to dramatically reduce the high drug prices that have long been a feature of the US market. 12 May 2025
Pharmaceutical
UK-based pharma major AstraZeneca has started construction on a new manufacturing site for small molecule drugs in Wuxi, a city in East China's Jiangsu province, underscoring its deepening investment in the country. 12 May 2025
Pharmaceutical
The UK government has announced a trade agreement with the USA. The UK-US Economic Prosperity Deal was agreed on Thursday May 8 with further details released on Friday May 9. 9 May 2025
Pharmaceutical
UK pharma major AstraZeneca has suffered a setback in its legal fight to block the US government's efforts to lower prescription drug prices, after a federal appeals court dismissed its challenge to Medicare’s negotiation powers. 9 May 2025
Pharmaceutical
As the US government, under President Donald Trump, is on the verge of announcing significant new tariffs on pharmaceutical imports, Indian drug-maker stocks continue to take a hammering on the bourses. 8 May 2025
Pharmaceutical
Pharmaceutical and Research Manufacturers of America (PhRMA) yesterday submitted comments to the US Department of Commerce on its Section 232 investigation of pharmaceuticals and pharmaceutical ingredients imported to the USA. 8 May 2025
Pharmaceutical
US President Donald Trump has signed an executive order attempting to restore a robust domestic manufacturing base for prescription drugs in the USA. 7 May 2025
Pharmaceutical
In the USA, the Trump administration is urging congressional Republicans to include a “most favored nation” (MFN) policy in their domestic policy package that would tie Medicaid drug payments to the lowest prices paid in other wealthy countries, a White House official confirmed to Inside Health Policy. 5 May 2025
Pharmaceutical
The head of the World Health Organization has issued a stark warning that sudden cuts to global health budgets, including by the USA, are putting years of medical progress in jeopardy. 2 May 2025
Pharmaceutical
A new report from Washington DC-based group No Patient Left Behind argues that foreign governments are underestimating the value of innovative medicines — a claim that adds fuel to the ongoing transatlantic debate on drug pricing and access. 2 May 2025
Pharmaceutical
The US Department of Health and Human Services has announced a sweeping change to the way new vaccines are evaluated, saying it will now require all future vaccines to undergo testing in placebo-controlled trials before being approved for use. 2 May 2025
Pharmaceutical
Shortly after Robert F Kennedy Jr was sworn in as Secretary of Health and Human Services (HHS), US President Donald Trump issued an executive order establishing the Make America Healthy Again Commission. 1 May 2025
Pharmaceutical
AstraZeneca posted a 10% rise in first-quarter revenue to $13.6 billion, supported by strong sales of cancer drugs and biopharmaceuticals. Core earnings per share climbed 21% to $2.49, while reported EPS advanced 34% to $1.88. Pre-tax profits increased 21% year-on-year to $3.4 billion. 29 April 2025
Pharmaceutical
The USA faces a serious risk of measles becoming endemic again, according to a new study modeling the impact of declining childhood vaccination rates, published in JAMA. 28 April 2025
Pharmaceutical
The Trump administration is reportedly revisiting a contentious drug pricing strategy that would tie US medicine prices to those paid in other developed nations, according to a Reuters report citing multiple industry sources. 23 April 2025
Generics
Research shows some 79% of the American public view the cost of prescription drugs as unreasonable, and lawmakers and regulators are increasingly convinced the industry charges too much for its products. 8 March 2019
Pharmaceutical
In Washington DC on Tuesday, the chief executives of half a dozen leading drugmakers defended the industry’s drug pricing rationale and shifted the blame for high prices onto the sector’s intermediaries. 27 February 2019
Pharmaceutical
Buyers of pharmaceutical stocks are watching closely as the heads of some of the world’s biggest drugmakers give evidence before Congress on their companies’ pricing practices. 26 February 2019
Pharmaceutical
Six chief executives of global pharma companies are due to face questions from senior US senators on Tuesday, as lawmakers from both legislative chambers progress inquiries into the industry’s pricing practices. 25 February 2019
Pharmaceutical
The US Health and Human Services Secretary Alex Azar and Inspector General Daniel Levinson have proposed a rule to lower prescription drug prices and out-of-pocket costs by encouraging manufacturers to pass discounts directly on to patients. 1 February 2019
Pharmaceutical
The US Senate Finance Committee, led by Chairman Charles Grassley, has initiated its own investigation into drug pricing, with ranking member Ron Wyden calling on drugmakers to come before the group to account for recent price rises. 31 January 2019
Pharmaceutical
There has been plenty of angry discourse but little real action around US medicine prices in recent years, but the end of 2018 and the beginning of 2019 are offering evidence of change that is making drug companies sit up and take notice. 21 January 2019
Pharmaceutical
A new report from RBC Capital Markets investigates the potential impact of the ongoing US Government shutdown on the pharmaceutical industry. 16 January 2019
Pharmaceutical
A powerful committee of the freshly inaugurated Democrat-led US House of Representatives has launched a far-ranging investigation into the drug pricing practices of the US pharmaceutical industry. 15 January 2019
Biotechnology
US President Donald Trump's administration has been criticized for continuing to defend 'flawed' proposals for changing the way that Medicare drug prices are set. 11 January 2019
Pharmaceutical
The US House of Representatives has approved a bill that would prevent drugmakers from overcharging Medicaid in the way Mylan (Nasdaq: MYL) was famously accused of doing. 12 December 2018
Pharmaceutical
The US Food and Drug Administration has issued a statement detailing a new strategic framework to promote the use of real-world evidence (RWE) and real-world data (RWD) in the drug development process. 7 December 2018
Pharmaceutical
Drug-making is sometimes pictured as one of the last surviving “traditional” industries, successfully resisting waves of change that have overtaken other businesses. 5 December 2018
Pharmaceutical
A coalition of 55 Conservative groups and activists have voiced major concerns at President Donald Trump’s proposals on Medicare drug prices. 29 November 2018
Pharmaceutical
New rules proposed by the administration of US President Donald Trump would see insurers participating in the government-backed Medicare scheme permitted to exclude pharmaceuticals if price rises outpaced inflation. 27 November 2018
Pharmaceutical
Much like US politics as a whole, opinions are divided about what the midterm results mean for prescription drug prices. 8 November 2018
Pharmaceutical
Roche was one of the worst hit by pledges made by US President Donald Trump on Medicare drug prices on Thursday. 26 October 2018
Pharmaceutical
US Food and Drug Administration Commissioner Scott Gottlieb has welcomed the signing of new legislation that empowers agencies to take a range of actions to tackle the ongoing epidemic of opioid abuse in the country. 25 October 2018
Pharmaceutical
The White House has signalled its intention to press ahead with proposals to force drugmakers to include drug pricing information in direct-to-consumer advertising, despite the apparent inability of Congress to sign up to the idea. 16 October 2018
Pharmaceutical
US President Donald Trump has signed legislation preventing so-called ‘gag clauses,’ used for years by pharmacy benefit managers to restrict access to cheaper off-plan options. 11 October 2018
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
Neurocrine develops and discovers treatments for neurological and endocrine-related diseases and disorders.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze